Skip to main content
. Author manuscript; available in PMC: 2015 Jul 31.
Published in final edited form as: AIDS. 2014 Jul 31;28(12):1759–1767. doi: 10.1097/QAD.0000000000000320

Table 4.

The Effect of Inflammatory Markers and Vitamin D on the Odds Ratio for HIV Status in a Logistic Regression Model of Bone Loss at the Trochanter Site

Odds Ratio (95% CI)a Adjusted Odds Ratio (95% CI)b p
HIV status 2.8 (1.1-7.2) 0.03
        IL-6 2.2 (0.8-5.9)c 0.12
        hsCRP 2.8 (1.1-7.2) 0.03
        sTNFR-I 2.7 (1.1-7.1) 0.04
        sTNFR-II 2.1 (0.8-5.8) c 0.14
        sVCAM-1 1.4 (0.5-4.2) c 0.51
        sICAM-1 2.1 (0.8-5.8) c 0.14
        25(OH)D 3 (1.1-7.9) 0.03
a

Unadjusted odds ratio for HIV status

b

Odds ratio for HIV status with each inflammatory marker or 25(OH)D added to the model separately

c

Odds ratio for HIV status changed by greater than 10% with this variable in the model

IL-6, interleukin-6; hsCRP, high sensitivity C-reactive protein; sTNFR-I, soluble tumor necrosis factor receptor-I; sTNFR-II, soluble tumor necrosis factor receptor-II; sVCAM-1, soluble vascular cell adhesion molecule-1; sICAM-1, soluble intracellular adhesion molecule-1; 25(OH)D, 25-hydroxy-vitamin D